-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Evonik announced that the company's recombinant non-animal-derived collagen platform Vecollan was officially commercialized
Evonik said that Vecollan is a new differentiated system solution specially designed by Evonik for the medical device industry, and is provided to customers through the Evonik Medical Device Technology Centers in Birmingham, Alabama, Darmstadt, Germany and Shanghai, China.
According to Evonik, animal-derived collagen is currently mainly used in the life science and pharmaceutical fields, so there are quality differences between different batches, the transmission of potential diseases or pathogens, and the possibility of causing adverse immune reactions or allergic reactions